- Breast cancer is common in older women, leading to concerns about treatment-related complications like Alzheimer’s disease.
- A study investigated the impact of hormone-modulating therapy (HMT) on the risk of developing Alzheimer’s and related dementias (ADRD) in women over 65.
- Researchers used data from breast cancer patients to study the association between HMT and ADRD risk.
- The study found that HMT was linked to a 7% reduced risk of developing ADRD in older women.
- Age, race, and the type of HMT were significant factors influencing ADRD risk, emphasizing the need for personalized treatment plans.
Source link
Oncology, Neurology